Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Research
Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Epidemiology 5: DNA Polymorphisms, Adducts, and Repair

PhIP-DNA adducts as a biomarker for prostate carcinogenesis

Deliang Tang, Jason Liu, Adnan T. Savera, Andrew Rundle, Christine Neslund-Dudas, Jie Yu, James J. Yang and Benjamin A. Rybicki
Deliang Tang
Columbia University, New York, NY, Henry Ford Health System, Detroit, MI, Henry Ford Health Sciences Center, Detroit, MI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jason Liu
Columbia University, New York, NY, Henry Ford Health System, Detroit, MI, Henry Ford Health Sciences Center, Detroit, MI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adnan T. Savera
Columbia University, New York, NY, Henry Ford Health System, Detroit, MI, Henry Ford Health Sciences Center, Detroit, MI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew Rundle
Columbia University, New York, NY, Henry Ford Health System, Detroit, MI, Henry Ford Health Sciences Center, Detroit, MI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christine Neslund-Dudas
Columbia University, New York, NY, Henry Ford Health System, Detroit, MI, Henry Ford Health Sciences Center, Detroit, MI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jie Yu
Columbia University, New York, NY, Henry Ford Health System, Detroit, MI, Henry Ford Health Sciences Center, Detroit, MI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James J. Yang
Columbia University, New York, NY, Henry Ford Health System, Detroit, MI, Henry Ford Health Sciences Center, Detroit, MI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benjamin A. Rybicki
Columbia University, New York, NY, Henry Ford Health System, Detroit, MI, Henry Ford Health Sciences Center, Detroit, MI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published April 2006
  • Article
  • Info & Metrics
Loading
Proc Amer Assoc Cancer Res, Volume 47, 2006

Abstract

2057

2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) is the most abundant heterocyclic amine in the human diet, and is formed during the cooking of meat. PhiP-DNA adducts provide a measure of chemical-specific genetic damage that has been associated with increased risk of cancer. This study examined the relationship between PhiP-DNA adducts measured by immunohistochemistry in nontumorous and tumorous prostatic epithelial cells. Study subjects were 125 men who underwent prostatectomy and were part of the Henry Ford Health System, in Detroit, Michigan. . The mean level of PhiP-DNA adducts in prostatic epithelial nontumor cells was significantly higher than the mean level of PhiP-DNA adducts in tumor cells (0.055 units) (p<0.0001). While tumor stage was not associated with PhIP-DNA adducts, adduct levels in both the nontumor (p=0.0002) and tumor (p=0.005) cells had a statistically significant positive association with Gleason grade. Only PhIP-DNA adducts in normal cells were significantly associated with prostate-specific antigen (PSA) levels (p<0.0001). Our findings suggest that PhiP-DNA adducts may be a biomarker for prostate carcinogenesis.

  • American Association for Cancer Research
Previous
Back to top
Cancer Research: 66 (8 Supplement)
April 2006
Volume 66, Issue 8 Supplement
  • Table of Contents

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
PhIP-DNA adducts as a biomarker for prostate carcinogenesis
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
PhIP-DNA adducts as a biomarker for prostate carcinogenesis
Deliang Tang, Jason Liu, Adnan T. Savera, Andrew Rundle, Christine Neslund-Dudas, Jie Yu, James J. Yang and Benjamin A. Rybicki
Cancer Res April 15 2006 (66) (8 Supplement) 486;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
PhIP-DNA adducts as a biomarker for prostate carcinogenesis
Deliang Tang, Jason Liu, Adnan T. Savera, Andrew Rundle, Christine Neslund-Dudas, Jie Yu, James J. Yang and Benjamin A. Rybicki
Cancer Res April 15 2006 (66) (8 Supplement) 486;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • The IL-6 G-174C polymorphism is associated with differences in the human serum proteome
  • Illumina® - based multiplexed genotyping indicates a role for altered DNA repair and genomic maintenance in susceptibility to benzene toxicity
  • Imaging and semiquantitation of polycyclic aromatic hydrocarbon (PAH)-DNA adducts in human cervix, vulva, placenta and prostate using immunohistochemistry (IHC) and the Automated Cellular Imaging System (ACIS)
Show more Epidemiology 5: DNA Polymorphisms, Adducts, and Repair
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement